Back to Results
First PageMeta Content
Financial economics / Financial regulation / Investment / Daewoo Securities / Daewoo / Securities research / Securities Act / Securities Exchange Act / U.S. Securities and Exchange Commission / United States securities law / United States Securities and Exchange Commission / 73rd United States Congress


RNL BioKS/Not Rated) Daewoo Securities Co., Ltd. David Kwon, Ph.D. +John Han +
Add to Reading List

Document Date: 2014-04-19 00:33:14

Open Document

File Size: 381,97 KB

Share Result on Facebook

City

Houston / Tokyo / Beijing / New York / /

Company

Daewoo Securities (Hong Kong) Ltd. / Daewoo Securities Co. Ltd. / RNL Bio (003190 KS/Not Rated) Daewoo Securities Co. Ltd. / Celltex / Daewoo Securities (America) Inc. / KDB Daewoo Securities / RNL Bio Distribution United Kingdom / Daewoo Securities (Europe) Ltd. / Chiyoda / Hang Seng Bank / KDB Daewoo Securities International Network Daewoo Securities Co. Ltd. / /

Continent

North America / /

Country

United States / Korea / United Kingdom / China / South Korea / /

Currency

USD / /

/

Event

M&A / Company Expansion / /

Facility

Hang Seng Bank Tower / GMP factory / First U.S. factory / Yusen Building / Twin Towers / /

IndustryTerm

treatment for Buerger's Disease / stem-cell technology / investment banking / financial services / technology transfer / /

Organization

FINRA / Shanghai Representative Office Unit / Korea Exchange / Korea Financial Investment Association / Kong Securities and Futures Commission / /

Person

Rick Perry / David Kwon / /

/

Position

board member / officer / director / broker-dealer / general information purposes / current governor / global stem cell leader / Representative / Analyst / /

ProvinceOrState

Texas / New York / /

RadioStation

KDB / /

Region

Central Hong Kong / /

Technology

stem cells / stem-cell technology / BioÊs technology / /

SocialTag